Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

956 evidence items · page 25 / 39

6.7 %An infection rate of 6.7% (16/238) was found for Epstein Barr Virus (EBV) in HIV-positive patients in Burkina Faso.

Burkina Fasovirus Epstein-Barrpublished 2017Mediterranean journal of hematology and infectious diseaseseurope_pmcdocument of 9 observations

82.6 %82.6% of malaria cases were diagnosed among 'residents'.

Burkina FasopaludismeHAL · Unilimdocument of 83 observations

46.1 %Artemether-lumefantrine had an unadjusted adequate clinical and parasitological response of 46.1% at day 28.

Burkina Fasopaludismepublished 2014Tropical medicine & international health : TM & IHeurope_pmcdocument of 4 observationsDOI 10.1111/tmi.12274

5.7 %The case-fatality rate of SARS-CoV-2 in Burkina Faso was 5.7% as of 21 June 2020.

Burkina FasoCOVID-19observed 21 June 2020HAL · Unilimdocument of 97 observations

A severe outbreak of dengue occurred in Burkina Faso in 2016.

Burkina Fasodengueobserved 2016published 2019Frontiers in veterinary scienceeurope_pmcdocument of 10 observationsDOI 10.3389/fvets.2019.00140

11.1 %The prevalence of asymptomatic malaria infection in the district of Barsalgho was 11.1%.

Burkina Fasopaludismeobserved 2013–2014published 2018Malaria journaleurope_pmcdocument of 3 observationsDOI 10.1186/s12936-018-2606-9

Anopheles arabiensis is the most prevalent species in Dioulassoba, a district of Bobo-Dioulasso city in Burkina Faso.

Burkina Fasopaludismeobserved 2012published 2014Acta tropicaeurope_pmcdocument of 5 observations

6 %Among 183 RPR-positive specimens from blood donors in Ouagadougou, Burkina Faso, 11 (6%) were confirmed positive for Treponema pallidum subsp pallidum by Polymerase Chain Reaction (PCR) testing.

Burkina FasoTreponema pallidum subsp pallidumpublished 2014The Pan African medical journaleurope_pmcdocument of 7 observations

17.6 %Hypoxaemia, diagnosed using routine pulse oximetry, was found in 17.6% of children aged under 5 years with serious respiratory and non-respiratory illnesses in primary care settings in Burkina Faso, Guinea, Mali and Niger.

Burkina Faso · Guinée · Mali · NigerhypoxaemiaHAL · Unilimdocument of 229 observations

13.14 %Among HIV-positive women, co-infection with Mycoplasma hominis and Ureaplasma urealyticum was identified in 13.14%.

Burkina Fasoco-infection M. hominis with U. urealyticumpublished 2011Journal of infection in developing countrieseurope_pmcdocument of 12 observationsDOI 10.3855/jidc.950

0 %Among SARS-CoV-2 cases in Burkina Faso as of 21 June 2020, 0% of deaths occurred in the <15 age group.

Burkina FasoCOVID-19observed 21 June 2020HAL · Unilimdocument of 97 observations

96.4 %At day 42, the PCR-corrected adequate clinical and parasitological response (ACPR) was 96.4% in the per-protocol population receiving the crushed-tablet formulation of dihydroartemisinin/piperaquine phosphate.

Burkina Fasopaludismepublished 2018Antimicrobial agents and chemotherapyeurope_pmcdocument of 10 observations

0.4 odds_ratioChorioamnionitis was associated with reduced risk of child parasitaemia (OR 0.4; 95% CI 0.1–1.0, P = 0.038).

Burkina Fasochorioamnionitispublished 2021Maternal & child nutritioneurope_pmcdocument of 11 observations

45 %At 4 months malaria prevalence was 45%.

Burkina Fasopaludismeobserved 4 monthspublished 2021Maternal & child nutritioneurope_pmcdocument of 11 observations

77.8 %The prevalence of asymptomatic malaria infection in the district of Gaoua was 77.8%.

Burkina Fasopaludismeobserved 2013–2014published 2018Malaria journaleurope_pmcdocument of 3 observationsDOI 10.1186/s12936-018-2606-9

1 caseOnly one case of clinical failure was detected among children treated with sulphadoxine-pyrimethamine (SP) in the province of Houet, Burkina Faso.

Burkina Fasopaludismepublished 2002Tropical medicine & international health : TM & IHeurope_pmcdocument of 6 observationsDOI 10.1046/j.1365-3156.2002.00952.x

18 %Parasitological resistance to chloroquine (CQ) was 18% (83 of 455) in children aged 6–59 months with uncomplicated malaria in the province of Houet, Burkina Faso.

Burkina Fasopaludismepublished 2002Tropical medicine & international health : TM & IHeurope_pmcdocument of 6 observationsDOI 10.1046/j.1365-3156.2002.00952.x

2.1 %The seroprevalence of syphilis in first-time volunteer blood donors in Burkina Faso in 2009 was 2.1%.

Burkina Fasosyphilisobserved 2009published 2012Tropical medicine & international health : TM & IHeurope_pmcdocument of 9 observationsDOI 10.1111/j.1365-3156.2011.02902.x

13.44 %In the town of Koudougou, 13.44% of households living more than 500 metres from waste have a very low risk of malaria contamination.

Burkina FasopaludismeHAL · Unilimdocument of 110 observations

60 %Mosquito populations resistant to the insecticides in the bed net exhibited high mortality of 60% in the presence of the Bti sugar patches.

Burkina Fasopaludismepublished 2019Journal of medical entomologyeurope_pmcdocument of 2 observations

1 %Annual referral rates of severe cases, regardless of SpO2 level, were 1% in Burkina Faso before the introduction of pulse oximetry.

Burkina Fasosevere casesobserved 2019HAL · Unilimdocument of 229 observations

13.8 %Pneumonias were the third aetiology of fever, representing 13.8% of cases.

Burkina FasopneumoniasHAL · Unilimdocument of 83 observations

77.9 %The positive predictive value for malaria infection using Paracheck® was 77.9% in under five children nationwide in Burkina Faso.

Burkina Fasopaludismepublished 2014Malaria journaleurope_pmcdocument of 7 observationsDOI 10.1186/1475-2875-13-101

2.36 odds_ratioKdr heterozygote males were more likely to mate than homozygote resistant males, with an odds ratio of 2.36 and P < 0.001.

Burkina Fasopaludismepublished 2015Heredityeurope_pmcdocument of 6 observations

80.11 microg/mLSaye, a traditional medicine from Burkina Faso containing Cochlospermum planchonii, Cassia alata, and Phyllanthus amarus, showed an in vivo IC(50) of 80.11 +/- 3.40 microg/mL against Plasmodium falciparum and Plasmodium berghei.

Burkina Fasopaludismepublished 2008Phytotherapy research : PTReurope_pmcdocument of 2 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.